Stock listing

Enveric Biosciences, Inc.

Selected listing: SLZ0 · MUN · EUR · DE

Enveric Biosciences, Inc. (Munich:SLZ0), Health Technology. Latest release Sep 15, 2026: Enveric Biosciences Secures New U.S. Patent Allowance…

SLZ0:MUNEURDEUpdated October 2, 2026

Ticker: Munich:SLZ0
Asset type: Stock
Sector: Health Technology
Industry: Pharmaceuticals: Other
Exchange: Munich
Currency: EUR

About Enveric Biosciences, Inc.

Enveric Biosciences, Inc. (Ticker: ENVB) is a public company based in the United States, focusing on the development of innovative therapies. The company aims to address unmet medical needs through its specialized approach.

Latest news from Enveric Biosciences, Inc.

Enveric Biosciences Secures New U.S. Patent Allowance for Next-Generation, Non-Hallucinogenic Mescaline Derivatives in EVM401 Series

September 15, 2026

Enveric Biosciences to Present at H.C. Wainwright 28th Annual Global Investment Conference

September 1, 2026

Enveric Biosciences Reports Financial Results and Provides Corporate Update for Second Quarter 2026

August 14, 2026

Enveric Biosciences Reports New Preclinical Data Supporting the Non-Hallucinogenic Profile of Lead Candidate EB-003

August 5, 2026

Enveric Biosciences Welcomes Final FDA Guidance for Psychedelic Drug Development

July 27, 2026

All Enveric Biosciences, Inc. news →

Research Enveric Biosciences, Inc.

Enveric Biosciences, Inc. company profile

View the public company page for Enveric Biosciences, Inc. on 6ix.

Enveric Biosciences, Inc. news

Read company news and market updates connected to Enveric Biosciences, Inc..

Enveric Biosciences, Inc. investor events

Find investor webinars, events, and replay context for Enveric Biosciences, Inc..